KIORA PHARMACEUTICALS, INC. (KPRX) Operating income 2018–2025
KIORA PHARMACEUTICALS, INC. (KPRX) annual operating income history from SEC filings — each fiscal year as reported.
-$12.8MFY2025 · since FY2018: -$10.8M → -$12.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.8M | -384.5% |
| FY2024 | $4.5M | +135.8% |
| FY2023 | -$12.6M | -2.3% |
| FY2022 | -$12.3M | +13.5% |
| FY2021 | -$14.2M | -107.3% |
| FY2020 | -$6.9M | — |
| FY2018 | -$10.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More KPRX financial trends
KPRX RevenueKPRX Net incomeKPRX Net marginKPRX Gross profitKPRX Gross marginKPRX Operating marginKPRX Operating cash flowKPRX Free cash flowKPRX Capital expendituresKPRX Return on equityKPRX Stock buybacksKPRX Dividends paidKPRX Total assetsKPRX Total liabilitiesKPRX Shareholders’ equityKPRX overview →